tiprankstipranks
Trending News
More News >
Avenue Therapeutics (ATXI)
:ATXI
US Market

Avenue Therapeutics (ATXI) Technical Analysis

Compare
331 Followers

Technical Sentiment

Overall Consensus
Neutral
10Bullish
2Neutral
9Bearish
Technical Analysis Consensus
Sell
3Bullish
2Neutral
4Bearish
Moving Average Consensus
Buy
7Bullish
0Neutral
5Bearish
Avenue Therapeutics’s (ATXI) Moving Averages Convergence Divergence (MACD) indicator is -0.01, suggesting Avenue Therapeutics is a Sell.
Avenue Therapeutics’s (ATXI) 20-Day exponential moving average is 0.24, while Avenue Therapeutics’s (ATXI) share price is $0.26, making it a Buy.
Avenue Therapeutics’s (ATXI) 50-Day exponential moving average is 0.37, while Avenue Therapeutics’s (ATXI) share price is $0.26, making it a Sell.

Avenue Therapeutics (ATXI) Pivot Points

Jun 05, 2025, 11:29 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.17
0.18
0.22
0.23
0.27
0.28
0.32
Fibonacci
0.18
0.20
0.21
0.23
0.25
0.26
0.28
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Avenue Therapeutics (ATXI) Moving Averages

Jun 05, 2025, 11:29 AM
Period
Simple
Exponential
MA5
0.25Buy
0.25Buy
MA10
0.23Buy
0.24Buy
MA20
0.23Buy
0.24Buy
MA50
0.26Buy
0.37Sell
MA100
0.77Sell
0.74Sell
MA200
1.50Sell
1.46Sell
Avenue Therapeutics’s (ATXI) 10-Day exponential moving average is 0.24, while Avenue Therapeutics’s (ATXI) share price is $0.26, making it a Buy.
Avenue Therapeutics’s (ATXI) 100-Day exponential moving average is 0.74, while Avenue Therapeutics’s (ATXI) share price is $0.26, making it a Sell.
Avenue Therapeutics’s (ATXI) stock price is $0.26 and Avenue Therapeutics’s (ATXI) 50-day simple moving average is 0.26, creating a Buy signal.
Avenue Therapeutics’s (ATXI) stock price is $0.26 and Avenue Therapeutics’s (ATXI) 100-day simple moving average is 0.77, creating a Sell signal.
Avenue Therapeutics’s (ATXI) stock price is $0.26 and Avenue Therapeutics’s (ATXI) 200-day simple moving average is 1.50, creating a Sell signal.

Avenue Therapeutics (ATXI) Technical Indicators

Jun 05, 2025, 11:29 AM
Name
Value
Implied Action
RSI (14)
50.89
Neutral
STOCH (9,6)
82.46
Sell
STOCHRSI (14)
82.46
Sell
MACD (12,26)
-0.01
Sell
ADX (14)
15.61
Buy
Williams %R
0.00
Sell
CCI (14)
91.66
Neutral
ATR (14)
0.04
-
Ultimate Oscillator
77.94
Buy
ROC
44.44
Buy
Avenue Therapeutics’s (ATXI) Relative Strength Index (RSI) is 50.89, creating a Neutral signal.
Avenue Therapeutics’s (ATXI) Trend Strength Indicator (ADX) is 15.61, creating a Buy signal.
Avenue Therapeutics’s (ATXI) Commodity Channel Index (CCI) is 91.66, creating a Neutral signal.
Avenue Therapeutics’s (ATXI) Price Rate of Change (ROC) is 44.44, creating a Buy signal.

FAQ

Is ATXI a Buy, Hold, or Sell?
Based on ATXI’s technical indicators, ATXI is a Hold.
    What is ATXI’s RSI (14)?
    ATXI’s RSI (14) is 50.89, which suggests ATXI is a Neutral.
      What is ATXI’s MACD?
      ATXI’s MACD is -0.01, which suggests ATXI is a Sell.
        What is ATXI’s 5-day moving average?
        ATXI’s 5-day moving average is 0.25, which suggests ATXI is a Buy.
          What is ATXI’s 20-day moving average?
          ATXI 20-day moving average is 0.23, which suggests ATXI is a Buy.
            What is ATXI’s 50-day moving average?
            ATXI’s 50-day moving average is 0.26, which suggests ATXI is a Buy.
              What is ATXI’s 200-day moving average?
              ATXI’s 200-day moving average is 1.50, which suggests ATXI is a Sell.
                What is ATXI’s Williams % R (14)?
                ATXI’s Williams % R (14) is 0.00, which suggests ATXI is a Sell.
                  What is ATXI’s CCI (14)?
                  ATXI’s CCI (14) is 91.66, which suggests ATXI is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis